2024年6月13日 · CD138 is expressed in most triple negative breast cancers (TNBC). The increased expression of CD138 may contribute to the formation of a tumor supportive …

"CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms". American Journal of Clinical Pathology. 121 (2): 254–263. doi: …

CD138 is a protein found on the surface of certain cells in the body. It plays a role in cell communication and adhesion, which means it helps cells stick together and send signals to …

Our observations suggest that low CD138 expression relates to i) poor prognosis, ii) immature phenotype and iii) low sensitivity to lenalidomide. The observed distinct characteristics of …

2025年3月14日 · CD138, also known as syndecan-1, is a key surface marker of plasma cells with critical roles in immune function. It is involved in cell adhesion, signaling, and interactions …

2019年9月12日 · Recognizing the presence of CD138 − PCM combined with morphology and other plasma cell markers, such as CD38 and MUM1, will be helpful for a correct diagnosis.

Syndecan-1 (CD138) is a transmembrane proteoglycan known to be expressed in various normal and malignant tissues. It is of interest because of a possible prognostic role of differential …

Within the hematopoietic system, CD138 is an excellent marker of plasmacytic differentiation. Based on its broad staining profile, CD138 reactivity for neoplastic cells is not a definitive …

2015年12月3日 · Syndecan-1 or CD138, is a heparan-sulfate coated glycoprotein, which is highly expressed on the surface of plasma cells and myeloma cells, important for adhesion and …

CD138 (syndecan-1, Sdc-1) is a member of the syndecan family that comprises heparan sulfate proteoglycans. CD138 is significant for cell-cell and cell-matrix interactions. In adult human …